Skip to content
EasyTelling

Science infrastructure

We turn science into business and impact

The global scientific infrastructure. 233 million articles in a living ecosystem connecting enterprises, universities, researchers and society.

EasyTelling — a infraestrutura que conecta ciência, mercado, governos e sociedade. Easy Telling Society Companies Researchers Universities
233M

scientific articles indexed

98%

accuracy vs. the original paper

13

years solving knowledge translation

<60s

to turn a paper into a market brief

Global problem

Science dies on the paper. Enterprises spend billions without it.

86%

of applied health research dies in a paper nobody reads

Research does not become products, innovations, solutions, technologies, startups or public policies.

US$ 782 bn

is what the world's top 1,000 companies spend on R&D each year

While science dies on the paper, enterprises spend billions searching for answers that might already be in published research.

Source: Chalmers, I. and Glasziou, P. (2009) ‘Avoidable waste in the production and reporting of research evidence’, The Lancet, 374(9683), pp. 86–89.

Global solution

The operating system for applied science.

We turn science into business at scale using AI and proprietary methods. The only global platform specialized in knowledge translation — a methodology that converts scientific discoveries into applicable solutions — built on 13 years of connecting science and markets.

Technology solutions
New businesses
Products
Startups
Sales arguments
Market strategies

How we do it

Four elements. One scientific marketplace. Zero hallucination.

01

Massive database

233 million articles from around the world, across every field, curated and organized.

02

Trained AI

Trained on our proprietary Knowledge Translation method to extract applications in a safe environment.

03

Proprietary method

Turns research into practical application — built on 13 years of the founder's experience.

04

Dozens of AI filters

Keep only the scientifically robust articles for each demand, extracting insights from that qualified set only.

Market validation

R&D teams at leading global companies already use and validate EasyTelling.

Across Brazil and the world — from chemicals to public sector, healthcare to defense.

Empresas & Indústrias

  • Suzano
  • Ajinomoto
  • Boston Scientific
  • P&G
  • Renault
  • Samarco
  • Loccus
  • Innoscience
  • WEDOC
  • LifeTime

Instituições

  • Embrapa
  • British Council
  • Ministério da Saúde
  • Fiocruz
  • WHO
  • UCL

Market validation

Why our clients chose EasyTelling.

“EasyTelling solved six of our challenges with zero hallucinations and brought seven times more relevant and unusual scientific sources than platforms like Scopus, Perplexity and ScienceDirect AI.”

Eva Mari Domingos da Silva

IP Consultant · Suzano

“EasyTelling quickly identified a scientific path to solve a 20-year-old technology challenge at a global mining client.”

Caio Kague

Head of Innovation & Projects · Innoscience

“In just one hour, EasyTelling's platform found a key piece of research for our product that saved us three to four months of experiments and all the costs involved.”

Gabryella Mendonça

Chief Scientist · inCapsula

What separates us (moat)

We are not a search engine. Anyone can search.

We apply science to real problems and connect those who have the solution with those who need it.

01

Application

We don't deliver articles — we deliver decisions. Every result comes with TRL, practical application and usage recommendation.

02

Connection

We map the researcher, enable contact and track implementation. The loop closes only when science and market truly meet.

03

Proprietary method

13 years of Knowledge Translation applied to AI. 98% accuracy extracting practical application from a paper.

04

Network effect

Companies, researchers and TTOs in the same loop. More challenges generate more briefs; more briefs generate more connections.

Our vision

We are building this future now.

  • 01

    Every scientific discovery finds someone who can turn it into a solution.

  • 02

    Enterprises and governments make evidence-driven decisions.

  • 03

    Researchers are recognized and rewarded for the impact they generate — not for how many articles they publish.

Let's turn science into solutions — together.

Come build with us the first global research marketplace that converts science into market solutions.